In addition, we confirmed increased HLA-E protein abundance following CD40L and IL-4 treatment of primary CLL and Ramos cells by immunoblotting (Fig. 1f). The gene discussed is CD40LG; the disease is B-cell chronic lymphocytic leukemia.